about
Advances in hepatitis E - I: virology, pathogenesis and diagnosis.Natural killer cell activation contributes to hepatitis B viral control in a mouse model.Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.Transforming growth factor β-activated kinase 1 transcriptionally suppresses hepatitis B virus replication.Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.Hepatitis B: treatment choice and monitoring for response and resistance.New therapies for chronic hepatitis B.HBV DNA Integration: Molecular Mechanisms and Clinical ImplicationsReactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.Eradication Strategies for Chronic Hepatitis B Infection.Association of Mutations in Toll-like Receptor 2 Signaling Genes With Fulminant Form of Hepatitis B-Related Acute Liver Failure.Activating the innate immune response to counter chronic hepatitis B virus infection.Antiviral therapies for managing viral hepatitis in lymphoma patients.Mechanisms of Hepatitis B Virus Persistence.Characteristics of systemic inflammation in hepatitis B-precipitated ACLF: Differentiate it from No-ACLF.Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection.Unimpaired immunogenicity of yeast-expressed hepatitis B surface antigen stored at elevated temperatures.New horizon for radical cure of chronic hepatitis B virus infection.A potent human neutralizing antibody Fc-dependently reduces established HBV infectionsInterleukin-1 Gene Cluster Haplotype Analysis in the Chronic Outcome Prediction of the Hepatitis B Virus Infection.Immune checkpoint blockade in infectious diseases.Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B.Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report.A multi-scale spatial model of hepatitis-B viral dynamics.Nucleic acid polymer REP 2139 and nucleos(t)ide analogues act synergistically against chronic hepadnaviral infection in vivo.The Chimpanzee Model of Viral Hepatitis: Advances in Understanding the Immune Response and Treatment of Viral Hepatitis.Combination Therapy Is the New Gene Therapy?Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection.Tim-3 blockade promotes iNKT cell function to inhibit HBV replication.Hepatitis B virus infection: Defective surface antigen expression and pathogenesis
P2860
Q30250366-A90F9EC9-6496-43DC-AFFE-6F4CC48B05E7Q33670723-8F46290B-6E3C-4322-A935-C63A0064205EQ36113029-4E3994EB-CF31-427F-BA04-C6BD6A329825Q36207245-77B16318-5F33-4CB2-A005-99ECDC140B8EQ37540212-1FE77AF3-6AC2-4DE6-A2E7-A76FFD12FBC9Q37550327-A2ADCB3D-933D-41D2-8F62-0D6DDF7B8E71Q37552210-D679FD32-577C-4B0A-9F14-31A6D5CFF583Q38707903-D3E7138A-1C4F-4606-B118-A45660C8EF44Q38725759-139B24B6-3374-4114-A608-362F4360426EQ38732528-3B9D45C5-474C-447C-8853-FEE0E47E6595Q38780065-FB9C5C41-C871-4ECA-B535-2020439B925FQ38837065-31751ADC-A791-48FA-8FCC-E3CA640E5410Q38886366-FE354DCB-453E-4F99-8DC4-407DFAC257D7Q38948529-756C96D8-46B3-47F0-AFF7-332AC33372CBQ38989625-679457E8-61C9-4D3A-B2C6-97B148A6C0D9Q40077350-D0308A80-B571-4BD7-BA89-D6608E6C7375Q40147201-0F4E5BB8-A394-481C-8FA8-E6301171E819Q40211036-8E102900-7326-41D2-8A61-090339666510Q40458714-E03E311A-BD65-4C66-80F0-D0111B725499Q40593364-9A4A542C-5DB8-469C-B419-A05F98137BB4Q41671765-2C690AE1-C96F-452D-92AE-45137A00E718Q41918156-1BED579C-FA4D-4D65-ADE0-8D26D8BFE053Q41921732-98F0FFF0-0346-4E53-BA28-C1E006022738Q41925064-E055DE8C-CC9D-484B-97FD-8621936CEB86Q41926688-2EE48FB0-1C3A-4F53-9DFA-37E18770600BQ45325391-BFE54AD9-0CF3-40E0-8A5E-64879F218F9CQ47151335-C7E2610A-C92E-4195-A8BF-1647748BC727Q47564306-34135DB1-84B3-4F6C-8CA7-B6727D85564FQ47608448-FE219E10-BBA1-4962-8797-F774B1EACDBDQ49608243-7009A246-8C36-404F-8DB0-CDB257C40637Q50000832-669DA132-8BFF-40A7-9AB4-136410069DDEQ54965814-F225226C-B116-4519-9679-42F7B0C3460DQ56944581-0750C3B1-C98D-48C5-B9CA-45AF063C2933
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Host-virus interactions in hepatitis B virus infection.
@en
type
label
Host-virus interactions in hepatitis B virus infection.
@en
prefLabel
Host-virus interactions in hepatitis B virus infection.
@en
P2860
P50
P1476
Host-virus interactions in hepatitis B virus infection
@en
P2093
Masanori Isogawa
P2860
P356
10.1016/J.COI.2015.06.016
P577
2015-07-15T00:00:00Z